Plasma derived versus biotechnological manufactured medicine
Journal Title: Iranian Journal of Blood and Cancer - Year 2011, Vol 3, Issue 3
Abstract
This article has no abstract.
Authors and Affiliations
Paul Strengers
Keywords
Related Articles
- EP ID EP370849
- DOI -
- Views 88
- Downloads 0
Over expression of Nrf2 in Umbilical Cord-derived Mesenchymal Stem Cells Up regulates Cytoprotective Genes, TXNRD1 and GCLC
Background: Mesenchymal stem cells (MSCs) are ideal cells for cell and gene therapy. However, the low survival of MSCs after transplantation has limited their applications. We aimed to evaluate the expression of cytoprot...
Detection of Factor VIII Inhibitors in Hemophilia A Patients
Background: Factor VIII administration to hemophilia A patients results in an immune response (inhibitor formation) which significantly complicates the therapy. The present study was performed to determine the prevalence...
Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children
Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and r...
Antioxidants and Their Role in Prevention of Cancer
This article has no abstract.
Disseminated Intravascular Coagulation in a Case of Brucellosis Misdiagnosed as Thrombotic Thrombocytopenia Purpura
This article has no abstract.